Last reviewed 2026-04-20 · How we verify

E2020

At a glance

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

• Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease (PHASE2)
• Donepezil Versus Non-drug Treatment in Alzheimer's Disease. (PHASE3)
• Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease (NA)
• Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease (NA)
• Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007) (PHASE1)
• Intravenous Infusion of Umbilical Cord Blood as an Adjunctive Treatment for Alzheimer's Disease (EARLY_PHASE1)
• Masitinib in Patients With Mild Alzheimer's Disease (PHASE3)
• Effect of Donepezil on Speech Recognition in Cochlear Implant Users (EARLY_PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.